9/14/2011 - Tragara Pharmaceuticals and the Multiple Myeloma Research Foundation Initiate Phase I Clinical Study of TG02 in Multiple Myeloma Patients

7/05/2011 - Tragara Pharmaceuticals Presents 12 Month Survival Data from CAPOXIGEM APRiCOT-L Trial at the World Conference on Lung Cancer in Amsterdam

6/11/2011 - Tragara Pharmaceuticals’ Capoxigem Prolongs Time-to-Progression and Overall Survival in Biomarker-Selected NSCLC Patients

6/6/2011 - Tragara to Present TG01 Poster at ASCO 2011 Annual Meeting "Patients Pathways Progress"

5/26/2011 - Tragara Pharmaceuticals’ Apricoxib Reverses EMT, a Key Process for Cancer Progression and Metastasis

4/1/2011 - Tragara to Present TG02 Poster at the 102nd AACR Annual Meeting "Innovation and Collaboration: The Path to Progress"

3/23/2011 - Tragara to Present Apricoxib Posters at the 2011 AACR 102nd Annual Meeting

1/22/2011 - Tragara to Present Apricoxib Posters at seventh annual Gastrointestinal Cancers Symposium, January 22, 2011

12/1/2010 - Tragara to Present TG02 Posters at the ASH 2010 Annual Meeting

11/15/2010 - Tragara to Present TG02 Posters at 22nd EORTC-NCI-AACR Symposium on “Molecular Targets and Cancer Therapeutics”

11/11/2010 - Patient Enrollment Complete in Tragara Pharmaceuticals' Phase II Trial of Capoxigem® in Pancreatic Cancer.

9/9/2010 - Tragara Pharmaceuticals Initiates Phase I Clinical Program for TG02.

6/7/2010 - Pancreatic Trial in Progress Poster Session.

5/6/2010 - Carrie Miller of Tragara Pharmaceuticals, Inc. will moderate a panel at the Bio Human Resources 2010 Conference on May 6, 2010.

4/8/2010 - Patient Enrollment Complete in Tragara Pharmaceuticals' Phase II Trial of Capoxigem® in Non-Small Cell Lung Cancer.

3/29/2010 - Multiple Myeloma Research Foundation (MMRF) Grants $1.0 Million to Tragara Pharmaceuticals, Inc. to Advance TG02 for Multiple Myeloma.

3/24/2010 - Apricoxib Poster to be Presented at AACR Annual Meeting, April 19, 2010.

3/23/2010 - Tragara to Present TG02 Poster at AACR Annual Meeting, April 19, 2010.

7/14/2009 - Tracy Lawhon, J.D. of Tragara Pharmaceuticals, Inc., will be a keynote speaker at the Sixth BVS La Jolla Biotech Event on July 22, 2009.

4/14/2009 - Apricoxib Phase I Study Results to be Presented at AACR in Denver, CO.

3/27/2009 - Tragara Pharmaceuticals Chief Executive Officer, Thomas M. Estok, to speak at Defined Health's annual pharma conference, Therapeutic Insight, taking place in New York City March 31st through April 2nd, 2009.

2/18/2009 - Christopher C. LeMasters, MBA, Chief Business Officer for Tragara Pharmaceuticals, to speak at Connect?Frameworks Workshops Drug Development in a Capital Constrained Economy, February 19, 2009

1/21/2009 - S*BIO and Tragara Announce an Exclusive Worldwide License Agreement for Novel Multi-kinase Inhibitor SB1317

5/8/2008 - Sara Zaknoen, Chief Medical Officer for Tragara Pharmaceuticals, to speak at UCSD Moores Cancer Center in San Diego, CA

4/2/2008 - Tragara Pharmaceuticals Chief Executive Officer, Thomas M. Estok, to speak at 2008 BIO-Europe Spring Conference in Madrid, Spain

3/13/2008 - Tracy Lawhon, J.D. of Tragara Pharmaceuticals, Inc., will be a keynote speaker and a participant in a panel discussion at Indiana University on April 2-3, 2008

1/28/2008 - Tragara Pharmaceuticals’ Chief Business Officer, Christopher C. LeMasters, to speak at 2008 BIO Asia Conference in Tokyo, Japan

3/13/2007 - Tragara Raises $40 million Series A Financing